Company / Profit Margin
BioRestorative Therapies, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-3959.4%
FY2025
5-year range
-96311.5% / -3959.4%
FY2021-FY2025
Trend
+44.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -96311.5% in FY2021 to -1259.9% in FY2016.
Based on SEC 10-K filings.
-3959.4% in FY2025 with a 5-year CAGR of +7308.2%.
Improved from -7145.2% to -3959.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +11478.6pp
- 5-Year Change
- +7308.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 44.6% year-over-year.
- Peak profit margin was recorded in FY2016.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3959.4% | +44.6% |
| FY2024 | -7145.2% | +0.0% |
| FY2023 | -7145.2% | +53.7% |
| FY2022 | -15438.0% | +84.0% |
| FY2021 | -96311.5% | -754.8% |
| FY2020 | -11267.6% | +0.1% |
| FY2019 | -11277.3% | +3.3% |
| FY2018 | -11660.1% | +50.9% |
| FY2017 | -23755.4% | -1785.5% |
| FY2016 | -1259.9% | +6.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026